Transactions
Alinta Energy Group’s restructuring
Date Announced:
12/09/2010
client:
Consortium of Senior Lenders of Alinta Energy Group
Status:
Closed – 03/2011
Value:
A$2.8 billion
European Directories S.A.’s reorganization
Date Announced:
12/09/2010
client:
Senior Coordinating Committee of European Directories S.A.
Status:
Closed – 12/2010
Value:
€2.3 billion
The O'Brien Family’s investment in R.J. O'Brien & Associates
Date Announced:
12/09/2010
client:
The O'Brien Family
Status:
Closed – 12/2010
Value:
Undisclosed
Life Technologies Corporation’s senior notes offering
Date Announced:
12/08/2010
client:
Life Technologies Corporation
Status:
Closed – 12/2010
Value:
$800 million
Ascent Media Corporation’s sale to Encompass Digital Media Inc. and Deluxe Entertainment Services Group, Inc.
Date Announced:
12/02/2010
client:
Ascent Media Corporation and its Board of Directors
Status:
Closed – 02/2011
Value:
$190 million
Affinity Group, Inc.’s senior secured notes offering
Date Announced:
11/29/2010
client:
Affinity Group, Inc.
Status:
Closed – 11/2010
Value:
$333 million
Coty Inc.'s acquisition of OPI Products, Inc.
Date Announced:
11/28/2010
client:
Coty Inc.
Status:
Closed – 12/2010
Value:
Undisclosed
CPI International, Inc.’s sale to Veritas Capital
Date Announced:
11/25/2010
client:
Special Committee of the Board of Directors of CPI International, Inc.
Status:
Closed – 02/2011
Value:
$525 million
Radio One, Inc.’s exchange offer
Date Announced:
11/23/2010
client:
Ad Hoc Group of Noteholders of Radio One, Inc.
Status:
Closed – 11/2010
Value:
$296 million
Aeroflex Holding Corp.’s initial public offering
Date Announced:
11/23/2010
client:
Aeroflex Holding Corp.
Status:
Closed – 11/2010
Value:
$267 million
Penhall Company’s recapitalization
Date Announced:
11/18/2010
client:
Centerbridge Partners L.P.
Status:
Closed – 11/2010
Value:
$291 million
Chemtura Corporation’s Chapter 11 Reorganization
Date Announced:
11/09/2010
client:
Ad Hoc Committee of Bondholders of Chemtura Corporation
Status:
Closed – 11/2010
Value:
$2.7 billion
Ares Life Sciences’s acquisition of 73.2% stake in Stallergenes S.A.
Date Announced:
11/09/2010
client:
Ares Life Sciences
Status:
Closed – 11/2010
Value:
€794 million
Renal Advantage Inc.’s combination with Liberty Dialysis
Date Announced:
11/03/2010
client:
Renal Advantage Inc.
Status:
Closed – 12/2010
Value:
Undisclosed